Evidence map›Paper›PMID 37869142›Full record

ArticleFrontiers in neurology2023

The many faces of gastrointestinal dysfunction in stiff person syndrome spectrum disorders.

Jacqueline Koshorek, Yujie Wang, Daniela Pimentel Maldonado, Maria I Reyes-Mantilla, Danielle Obando, Alexandra Balshi, Michael Comisac, Pankaj Jay Pasricha, Scott D Newsome

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Jacqueline KoshorekDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Yujie WangDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Daniela Pimentel MaldonadoDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Maria I Reyes-MantillaDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Danielle ObandoDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Alexandra BalshiDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Michael ComisacDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Pankaj Jay PasrichaDepartment of Gastroenterology, Johns Hopkins School of Medicine, Baltimore, MD, United States.
Scott D NewsomeDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Johns Hopkins Medicine · USJohns Hopkins University · USUniversity of Washington · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The effect of stiff person syndrome spectrum disorders (SPSD) on the gastrointestinal tract (GIT) is unknown. This case series aims to characterize the prevalence and types of GI dysfunction in individuals with SPSD. Methods: A retrospective chart review included individuals diagnosed with SPSD with descriptors of GI symptoms in their medical records. SPSD phenotypes, type of motility test performed, and dysmotility pattern (upper, lower, or diffuse) were assessed. Descriptive statistics and univariate chi-square analyses were utilized. Results: Of 240 individuals with SPSD, 32% reported GI symptoms, most were female (83.1%), and white (74%), with a median age at time of GI symptom onset of 50 ± 13 years. Most common symptoms reported were dysphagia (45%), constipation (40%), and nausea/vomiting (23%). Most individuals had classic SPS (47%) followed by SPS-plus (29%) and 82.9% were positive for serum antiGAD65 antibodies. Of 36 patients that underwent at least one GI motility test, 26 had evidence of upper, lower, or diffuse GI dysmotility (44.4%, 17%, and 4%, respectively). The group who did not undergo testing had a higher proportion of patients with DM. Discussion: There is a high prevalence of GI symptoms and transit abnormalities in patients with SPSD. Future prospective, longitudinal studies are warranted to further assess GI symptoms in the context of SPSD and to determine if individuals with GI symptoms differ in prognosis or treatment response from those without GI symptoms. In the meantime, there should be a low threshold for motility testing in patients with SPSD.

Indexed as

GAD65 antibodiesgastrointestinal dysfunctionGI dysmotilitystiff person spectrum disorderstiff person syndrome

Identifiers

PMID37869142
PMCPMC10587580
OpenAlexW4387406976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.